Erica Villa Selected Research

Estrogens (Estrogen)

1/2023	Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review.
12/2014	Female gender in the setting of liver transplantation.
2/2013	Influence of age and gender before and after liver transplantation.
1/2012	Reproductive status is associated with the severity of fibrosis in women with hepatitis C.
1/2008	Role of estrogen in liver cancer.
7/2002	Sex hormones and liver cancer.
6/2002	Hepatocellular carcinoma: role of estrogen receptors in the liver.
4/2002	Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erica Villa Research Topics

Disease

37	Fibrosis (Cirrhosis) 03/2024 - 01/2002
28	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 06/2002
18	Infections 10/2023 - 05/2002
18	Liver Diseases (Liver Disease) 10/2023 - 06/2002
17	Neoplasms (Cancer) 12/2023 - 04/2002
9	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 12/2014
9	Inflammation (Inflammations) 11/2022 - 03/2011
8	Non-alcoholic Fatty Liver Disease 11/2021 - 02/2013
7	Chronic Hepatitis C 10/2023 - 03/2011
7	Hemorrhage 01/2023 - 01/2010
6	Chronic Hepatitis B 01/2019 - 09/2004
6	Liver Neoplasms (Liver Cancer) 01/2018 - 07/2002
5	Portal Hypertension 10/2023 - 01/2014
5	Ascites 01/2023 - 01/2018
5	Thrombosis (Thrombus) 01/2018 - 11/2012
4	Hepatitis 01/2023 - 01/2011
4	Fatty Liver 11/2021 - 04/2016
4	Hepatitis C 01/2020 - 12/2011
4	End Stage Liver Disease 01/2019 - 10/2013
3	Anemia 01/2024 - 11/2014
3	Carcinogenesis 01/2022 - 07/2002
3	Hepatitis B 01/2019 - 12/2014
2	Fatigue 01/2024 - 01/2023
2	Cholangiocarcinoma 12/2023 - 06/2022
2	Chemical and Drug Induced Liver Injury 01/2023 - 06/2015
2	Obesity 01/2023 - 06/2016
2	Brain Diseases (Brain Disorder) 01/2023 - 01/2018
2	Hepatic Encephalopathy 01/2023 - 01/2018
2	Insulin Resistance 01/2022 - 04/2016
2	Disease Progression 01/2021 - 07/2002
2	COVID-19 01/2021 - 01/2021
2	Alcoholic Fatty Liver 01/2020 - 06/2016
2	Weight Gain 01/2020 - 06/2019
2	Hypertension (High Blood Pressure) 10/2018 - 06/2016
2	Body Weight (Weight, Body) 01/2018 - 04/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 04/2016
2	Varicose Veins (Varicose Vein) 01/2018 - 01/2018
2	Cholestasis 01/2018 - 10/2015
2	Acute Liver Failure (Fulminant Hepatic Failure) 04/2016 - 12/2014
1	Avitaminosis (Vitamin Deficiency) 01/2023
1	Craniocerebral Trauma (Head Injury) 01/2023
1	Iron Deficiencies 01/2023

Drug/Important Bio-Agent (IBA)

17	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2009
8	Estrogens (Estrogen)FDA Link 01/2023 - 04/2002
7	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 12/2011
6	InterferonsIBA 01/2019 - 08/2011
5	Angiopoietin-2IBA 12/2023 - 01/2018
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2011 - 05/2002
4	Hormones (Hormone)IBA 01/2023 - 06/2002
4	glecaprevir and pibrentasvirIBA 01/2023 - 01/2019
4	AnticoagulantsIBA 09/2019 - 01/2014
4	Ribavirin (Virazole)FDA LinkGeneric 11/2018 - 08/2016
4	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 01/2004
4	Estrogen ReceptorsIBA 02/2003 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2002
3	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023 - 07/2002
3	Hemostatics (Antihemorrhagics)IBA 01/2023 - 01/2014
3	pevonedistatIBA 11/2021 - 02/2015
3	UbiquitinIBA 11/2021 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	Ritonavir (Norvir)FDA Link 11/2018 - 01/2017
3	dasabuvirIBA 11/2018 - 01/2017
3	ombitasvirIBA 11/2018 - 01/2017
3	paritaprevirIBA 11/2018 - 01/2017
3	CreatinineIBA 01/2018 - 01/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 01/2018
2	AlbuminsIBA 08/2023 - 10/2018
2	SodiumIBA 01/2023 - 01/2002
2	AndrogensIBA 11/2022 - 07/2002
2	LipidsIBA 11/2021 - 02/2018
2	Messenger RNA (mRNA)IBA 10/2021 - 04/2002
2	CytokinesIBA 10/2021 - 01/2021
2	tepotinibIBA 08/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 02/2019
2	regorafenibIBA 11/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 02/2018 - 10/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2018 - 11/2012
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2016 - 11/2014
2	Estradiol (Delestrogen)FDA LinkGeneric 09/2015 - 01/2012
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2014 - 11/2012
2	InterleukinsIBA 12/2011 - 08/2011
2	Estrogen Receptor alphaIBA 07/2002 - 04/2002
1	Fibrinogen (Factor I)FDA Link 03/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023
1	Fetal Proteins (Fetoprotein)IBA 10/2023
1	Propranolol (Inderal)FDA LinkGeneric 10/2023
1	Human Serum Albumin FDA LinkGeneric 08/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	NivolumabIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	IronIBA 01/2023

Therapy/Procedure

22	Therapeutics 10/2023 - 03/2006
16	Liver Transplantation 01/2023 - 05/2002
3	Transjugular Intrahepatic Portasystemic Shunt 01/2023 - 01/2018
3	Ligation 01/2018 - 10/2015
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023 - 01/2019
2	Transplantation 01/2018 - 02/2013
1	Duration of Therapy 10/2023
1	Patient Readmission 01/2023